Soutenir la recherche

Publications et ressources

Trier par :
Afficher :
1-10 sur 339

Resistance analysis in patients with genotype 1-6 HCV infection treated with sofosbuvir/velpatasvir in the phase III studies

Christophe HEZODE, N Reau, ES Svarovkaia, BP Doehle, R Shanmugam, H Dvory-Sobol, C Hedskog, J McNally, A Osinusi, DM Brainard, MD Miller, H Mo, SK Roberts, JG O'Leary, SD Shafran, S Zeuzem,

J Hepatol 01/05/2018;68(5) : 895-903 10.1016/j.jhep.2017.11.032. 06/12/2017

Integrated Care for the Use of Direct-acting Antivirals in Patients With Chronic Hepatitis C and Substance Use Disorder

JB Trabut, C Barrault, H Charlot, D Carmona, A Bourdel, M Benslimane, Murielle FRANCOIS, W Kini-Matondo, R Causse, F Roudot-Thoraval, Christophe HEZODE,

J Addict Med 26/04/2018;- : - 10.1097/ADM.0000000000000415

Detection of numerous HIV-1/MO recombinants in France.

F De Oliveira, P Cappy, V Lemee, A Moisan, C Pronier, L Bocket, Magali BOUVIER-ALIAS, ML Chaix, E Gault, O Morvan, JD Poveda, V Schneider, M Wirden, E Alessandri-Gradt, T Mourez, JC Plantier,

AIDS 16/04/2018;- : - 10.1097/QAD.0000000000001814. 16/04/2018

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

P Houssel-Debry, A Coilly, C Fougerou-Leurent, C Jezequel, C Duvoux, V De Ledinghen, S Radenne, N Kamar, V Leroy, V Di Martino, L D'Alteroche, V Canva, F Conti, J Dumortier, H Montialoux, P Lebray, D Botta-Fridlund, A Tran, C Moreno, C Silvain, C Besch, P Perre, C Francoz, A Abergel, F Habersetzer, M Debette-Gratien, C Cagnot, A Diallo, Stephane CHEVALIEZ, E Rossignol, A Veislinger, JC Duclos-Vallee, GP Pageaux, ANRS CO23 CUPILT study group.

Hepatology 10/04/2018;- : - 10.1002/hep.29918

EASL Recommendations on Treatment of Hepatitis C 2018.

Jean-Michel PAWLOTSKY, F Negro, A Aghemo, M Berenguer, O Dalgard, G Dusheiko, F Marra, M Puoti, H Wedemeyer, European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver.

J Hepatol. 09/04/2018;pii: S0168-8278(18)31968-8 : - 10.1016/j.jhep.2018.03.026.

Approaches for simplified HCV diagnostic algorithms

Slim FOURATI, JJ Feld, Stephane CHEVALIEZ, N Luhmann,

J Int AIDS Soc. 01/04/2018;21 Suppl 2 : e25058 10.1002/jia2.25058.

Role of hepatitis C virus core antigen assay in hepatitis C care in Africa

M Lemoine, Z Mohamed, Stephane CHEVALIEZ, Y Shimakawa, J Rwegasha,

Lancet Gastroenterol Hepatol 01/04/2018;3(4) : 223-224 10.1016/S2468-1253(18)30039-6 07/03/2018

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

V De Ledinghen, C Laforest, Christophe HEZODE, S Pol, A Renault, L Alric, D Larrey, S Metivier, A Tran, C Jezequel, D Samuel, F Zoulim, C Tual, A Pailhe, S Gibowski, M Bourliere, E Bellissant, Jean-Michel PAWLOTSKY,

Clin Infect Dis. 19/03/2018;66(7) : 1013-1018 10.1093/cid/cix916.

Afficher :
1-10 sur 339